| 000 | 01683 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250515223203.0 | ||
| 264 | 0 | _c20100601 | |
| 008 | 201006s 0 0 eng d | ||
| 022 | _a2151-4658 | ||
| 024 | 7 |
_a10.1002/acr.20207 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFarragher, Tracey M | |
| 245 | 0 | 0 |
_aBenefit of early treatment in inflammatory polyarthritis patients with anti-cyclic citrullinated peptide antibodies versus those without antibodies. _h[electronic resource] |
| 260 |
_bArthritis care & research _cMay 2010 |
||
| 300 |
_a664-75 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntirheumatic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aArthritis _xblood |
| 650 | 0 | 4 |
_aArthritis, Rheumatoid _xblood |
| 650 | 0 | 4 |
_aAutoantibodies _xblood |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 | _aDisease Progression |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLongitudinal Studies |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPeptides, Cyclic _ximmunology |
| 650 | 0 | 4 | _aPredictive Value of Tests |
| 650 | 0 | 4 | _aRegistries |
| 650 | 0 | 4 |
_aRheumatoid Factor _xblood |
| 650 | 0 | 4 | _aSeverity of Illness Index |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aLunt, Mark | |
| 700 | 1 | _aPlant, Darren | |
| 700 | 1 | _aBunn, Diane K | |
| 700 | 1 | _aBarton, Anne | |
| 700 | 1 | _aSymmons, Deborah P M | |
| 773 | 0 |
_tArthritis care & research _gvol. 62 _gno. 5 _gp. 664-75 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/acr.20207 _zAvailable from publisher's website |
| 999 |
_c19816602 _d19816602 |
||